Early MRI scans shrink after treatment to help spot prostate cancer recurrence sooner

Men with localized prostate cancer face a tough choice: how to treat the disease without missing the cancer or causing unnecessary harm. A new trial is testing a specific way to use MRI scans to guide this treatment. Ninety-seven men with unfavorable-intermediate or high-risk cancer received definitive radiotherapy combined with androgen deprivation therapy. This treatment blocks male hormones that fuel the cancer. Doctors also used MRI scans to see the tumor before treatment started and while it was happening. These scans help doctors see exactly where the cancer is and how big it is. The goal is to target the radiation precisely to the tumor and spare healthy tissue. This approach might also help catch the cancer returning early. Early detection of recurrence could mean better outcomes for patients in the future. Safety was not a concern in this early report. No serious side effects were reported during the initial phase of the trial. The study is still ongoing. Researchers will wait to see if these imaging changes truly predict who will experience a recurrence later on. For now, the data suggests that taking scans before and after hormone therapy gives a clearer picture of the tumor. This clarity helps doctors plan better radiation boosts. It also simplifies the workflow for medical teams. Patients might benefit from more accurate treatment and fewer complications. The results are preliminary but promising for men facing this diagnosis.